These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18782432)

  • 81. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Geerts WH; Bergqvist D; Pineo GF; Heit JA; Samama CM; Lassen MR; Colwell CW
    Chest; 2008 Jun; 133(6 Suppl):381S-453S. PubMed ID: 18574271
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Pharmacological Thromboprophylaxis in Acutely Ill Hospitalized Medical Patients].
    Kantor B; Poénou G; Plaisance L; Toledano E; Mekhloufi Y; Helfer H; Djennaoui S; Mahé I
    Rev Med Interne; 2022 Jan; 43(1):9-17. PubMed ID: 33895004
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The Prophylaxis of Venous Thromboembolism.
    Encke A; Haas S; Kopp I
    Dtsch Arztebl Int; 2016 Aug; 113(31-32):532-8. PubMed ID: 27581506
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Thromboembolic prophylaxis in hospitalized medical patients].
    Braekkan S; Grimsgaard S; Hansen JB
    Tidsskr Nor Laegeforen; 2007 May; 127(9):1177-80. PubMed ID: 17479133
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Approaches for optimizing venous thromboembolism prevention in injured patients: Findings from the consensus conference to implement optimal venous thromboembolism prophylaxis in trauma.
    Teichman AL; Cotton BA; Byrne J; Dhillon NK; Berndtson AE; Price MA; Johns TJ; Ley EJ; Costantini T; Haut ER
    J Trauma Acute Care Surg; 2023 Mar; 94(3):469-478. PubMed ID: 36729884
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Venous Thromboembolism Incidence and Prophylaxis Use After Gastrectomy Among Korean Patients With Gastric Adenocarcinoma: The PROTECTOR Randomized Clinical Trial.
    Jung YJ; Seo HS; Park CH; Jeon HM; Kim JI; Yim HW; Song KY
    JAMA Surg; 2018 Oct; 153(10):939-946. PubMed ID: 30027281
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Use of New Oral Anticoagulants in the Treatment of Venous Thromboembolism and Thrombotic Prophylaxis.
    Akin M; Schäfer A; Akin I; Widder J; Brehm M
    Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):92-6. PubMed ID: 26666324
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Low-molecular-weight heparin for thromboprophylaxis.
    Camporese G; Bernardi E
    Curr Opin Pulm Med; 2009 Sep; 15(5):443-54. PubMed ID: 19593139
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bleeding risk assessment for venous thromboembolism prophylaxis.
    Chindamo MC; Marques MA
    J Vasc Bras; 2021 Apr; 20():e20200109. PubMed ID: 34093680
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Deep venous thrombosis in the medically ill.
    Ageno W; Turpie AG
    Curr Hematol Rep; 2002 Sep; 1(1):73-8. PubMed ID: 12901127
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pentasaccharides for the prevention of venous thromboembolism.
    Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism.
    Giustozzi M; Franco L; Agnelli G; Verso M
    Trends Cardiovasc Med; 2023 Aug; 33(6):336-343. PubMed ID: 35150850
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements.
    Nielen JT; Dagnelie PC; Emans PJ; Veldhorst-Janssen N; Lalmohamed A; van Staa TP; Boonen AE; van den Bemt BJ; de Vries F
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1245-1252. PubMed ID: 27594378
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Venous thromboembolism and anticoagulant therapy in pregnancy.
    Greer IA
    Gend Med; 2005; 2 Suppl A():S10-7. PubMed ID: 16551552
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.
    Mahlab-Guri K; Otman MS; Replianski N; Rosenberg-Bezalel S; Rabinovich I; Sthoeger Z
    Medicine (Baltimore); 2020 Feb; 99(7):e19127. PubMed ID: 32049830
    [TBL] [Abstract][Full Text] [Related]  

  • 97. New versus established drugs in venous thromboprophylaxis: efficacy and safety considerations related to timing of administration.
    Tribout B; Colin-Mercier F
    Am J Cardiovasc Drugs; 2007; 7(1):1-15. PubMed ID: 17355162
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis.
    Lyman GH
    Cancer; 2011 Apr; 117(7):1334-49. PubMed ID: 21425133
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Cancer and thrombosis: implications of published guidelines for clinical practice.
    Khorana AA
    Ann Oncol; 2009 Oct; 20(10):1619-30. PubMed ID: 19561038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.